Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Viral-associated cancers and disorders, Lymphoma Diagnosis and Treatment, HIV/AIDS drug development and treatment, and HIV Research and Treatment.
Impact of SARS-CoV-2 vaccines and recent chemotherapy on COVID-19 morbidity and mortality in patients with soft tissue sarcoma: an analysis from the OnCovid registry
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium
SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study
Time-Dependent COVID-19 Mortality in Patients With Cancer
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
Determinants of enhanced vulnerability to COVID-19 in UK cancer patients: a European Study
UCL Discovery (University College London) 2021cited by 0position: middle
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort Study
The prognostic and predictive role of hyponatremia in patients with advanced non-small cell lung cancer (NSCLC) with bone metastases
British HIV Association guidelines for the treatment of <scp>HIV</scp>‐1‐positive adults with antiretroviral therapy 2015
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice
<scp>B</scp>ritish <scp>HIV</scp> Association guidelines for <scp>HIV</scp>‐associated malignancies 2014
Prognostic factors for advanced‐stage human immunodeficiency virus‐associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi‐institutional retrospective study
British HIV Association guidelines for the treatment of <scp>HIV</scp>‐1‐positive adults with antiretroviral therapy 2012 (Updated November 2013. All changed text is cast in yellow highlight.)
Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma
Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study
British HIV Association guidelines for the treatment of <scp>HIV</scp>‐1‐positive adults with antiretroviral therapy 2012
PD-1 Expression on Natural Killer Cells and CD8 <sup>+</sup> T Cells During Chronic HIV-1 Infection
Short Communication: NKG2C <sup>+</sup> NK Cells Contribute to Increases in CD16 <sup>+</sup> CD56 <sup>−</sup> Cells in HIV Type 1 <sup>+</sup> Individuals with High Plasma Viral Load